| PERIOD ENDING | 28-Feb-09 | 1-Mar-08 | 3-Mar-07 | | Total Revenue | 530,742 | 575,781 | 547,317 | | Cost of Revenue | 341,734 | 354,468 | 330,473 | | | Gross Profit | 189,008 | 221,313 | 216,844 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 172,295 | 166,362 | 145,229 | | Non Recurring | 4,557 | 10,512 |
-
| | Others | 26,264 | 22,603 | 21,687 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,108) | 21,836 | 49,928 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,809 | 4,662 | 5,116 | | Earnings Before Interest And Taxes | (12,299) | 26,498 | 55,043 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (12,299) | 26,498 | 55,043 | | Income Tax Expense | (4,215) | 9,479 | 21,357 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,084) | 17,018 | 33,686 | | | Non-recurring Events | | Discontinued Operations | (4,666) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (12,751) | 17,018 | 33,686 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,751) | $17,018 | $33,686 |
|
1.48% Nasdaq 
Income Statement
